SARI
Overview
SARI is a Chinese biotech investment company focusing on cutting-edge biotechnology and life-science opportunities, particularly in targeted cancer therapy. SARI's investment strategy centers on identifying and supporting innovative biotech companies that are developing advanced therapies, with a strong emphasis on oncology. The firm seeks to collaborate with organizations that align with its mission to advance cancer treatment through scientific innovation. SARI's portfolio includes significant investments in companies such as NMS Group S.p.A., an Italian biopharmaceutical company specializing in oncology drug discovery and development. This acquisition reflects SARI's commitment to expanding its global presence and enhancing its capabilities in the biotech sector. SARI's investment philosophy is grounded in fostering sustainable growth and innovation within the biotech industry. By leveraging its expertise and resources, the firm aims to drive advancements in medical treatments, particularly in the field of oncology, to improve patient outcomes worldwide.
Investment Focus
- Innovative biotech companies
- Alignment with oncology focus
- Potential for sustainable growth
Portfolio Companies
Reach SARI directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about SARI
What sectors does SARI invest in?
SARI invests in Life Sciences, Biotechnology and Oncology, and is based in Shanghai, China. SARI is listed as a corporate vc in the ConnectSafely investor database.
What stage does SARI invest at?
SARI backs companies at Early Stage, Growth and Late Stage.
Which regions does SARI invest in?
SARI invests across China and Italy.
Who are the partners at SARI?
Team members listed for SARI include Sarai Da Silva (Founder).
What companies has SARI invested in?
SARI's portfolio includes NMS Group S.p.A..
How do I contact SARI?
SARI's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
